CGTX
Cognition Therapeutics Inc
Mentions (24Hr)
100.00% Today
Reddit Posts
Bought (Yolo’d) $10k into CGTX
CGTX WHATs happening with this 140% up
Mentions
Still betting on IXHL and CGTX, CGTX announced that July 8th would be the day they would have an fda meeting with trial results and future plans, but nothing happened today? Giving it a few more days hopefully they bring out some new information…
CTM BTBT USAS SKYX WOLF ARBK CGTX ICU GRYP All in the red lmao ..😢
What’s happening with CGTX? I sold 500 shares at .63 but I’m holding 1900 at an average of .53. SL set at .45.
Here I was thinking I was going to make money on CGTX today and then NCNA just pops in and says NO ME.
CGTX rising slowly right before the fda meeting, but it does this everyday im still holding tho
Im DEEP in CGTX and hoping tomorrows fda meeting gives it some kinda of little boost maybe up to 0.8 even ill take any wins after all the losses I’ve been having. Just tryna see if anyone else is in the same situation or if anyone thinks its a bad idea?
CGTX, fda meeting tomorrow + they will discuss phase 3 plans for their trials. Can someone tell me if this sounds like it would be a good catalyst, I’m guessing so but I’ve only recently started trading
Tmrws FDA meeting better be a strong catalyst for CGTX
CGTX has to be going up again today in AH
I think CGTX is on a safe dip, its volumes going up so I won’t sell I’ll just believe in it
CGTX playing with my feelings I’m practically all in, idk if I should sell while there’s a profit or be patient
CGTX rising till it hits that dolla
This is the 3rd post about CGTX
Yeah yeah, nothing like losing money on biotech penny stocks. That said, Cognition Therapeutics (CGTX) looks promising.
Is there a minimum buy in for CGTX?
Oh you don't have to tell me about SAVA, I got out at a 90% loss. One of my biggest losses since I have started investing (probably the second biggest by money amount). Actually with CGTX I am mich more interested in their Lewy Body Dementia drug, the phase 2 results were spectacular! Their Alzheimer's trial is just a bonus.
Anyone on MIST and/or CGTX? Thoughts?
Exciting Updates from My Recent CGTX Video Conference Hey everyone, I wanted to share some insights from a video conference I had yesterday with Mike, Lisa, and a few other investors. The call left me even more confident in CGTX’s future. The Science Is Solid: The team is truly passionate, and the science behind CGTX (c1812) is strong. There’s real innovation happening here, and the leadership’s commitment is clear. No Reverse Split Planned: A key takeaway from our discussion: there are no plans for a reverse split. Management is focused on long-term growth and shareholder value. Behind-the-Scenes Progress: Lisa is working harder than ever to ensure we remain fully compliant with Nasdaq requirements. There’s a lot happening behind the curtain, and the team is making all the right moves to position CGTX for success. A Golden Opportunity: In my view, this is a long-term play with tremendous potential. The current price doesn’t reflect the value being built. I truly believe we’re looking at a hidden gem—a little gold mine waiting to be discovered. If you’re considering your next move, now could be the perfect time to get in. Big things are happening
CGTX, I’ve seen 4 or 5 different sightings that call this stock a strong buy. But my DD doesn’t show anything amazing about this stock. What am I missing here?
CGTX, keep your eye on it PURCHASE, N.Y., March 10, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the "Company" or "Cognition") (NASDAQ: CGTX), a clinical stage company developing product candidates that treat neurodegenerative disorders, (the "Company" or "Cognition"), announced that President and CEO Lisa Ricciardi will present live at the Life Sciences Virtual Investor Conference on March 13, 2025 at 9:30 a.m. ET. In her presentation, Ms. Ricciardi will review plans for 2025 to support the advancement of zervimesine (CT1812) in Alzheimer's disease and dementia with Lewy bodies following the Company's positive Phase 2 data readouts.
Missed SYTA, TRNR, CGTX, and IPA. Dude how. I’m staring at a screener 😭
CGTX all the way back down again lol. I wonder if it’ll pop off at market open
CGTX looking prime for takeoff
Agreed - big day based on big news https://www.stocktitan.net/news/CGTX/cognition-therapeutics-successfully-passes-pre-defined-futility-evmaa5c8l30c.html
Huge news for GCTX !!! https://www.stocktitan.net/news/CGTX/cognition-therapeutics-successfully-passes-pre-defined-futility-evmaa5c8l30c.html
CGTX, CTM, OPPT, LITM, UAMY. Cgtx isn't going great at the moment, but it's working on a drug targeting Lewy Body Dementia and they just met their goal in their mid-stage trial. I'm a nurse, I've worked with people who have dementia, my family has had it, so I'm holding this one because I know that if the results are promising and it successfully completes its trials, the drug can be tested on other dementias, alzheimers, etc. Enough said. As for the rest, plenty of other AU generated spiels about them.
Anyone watching CGTX or PTIX?
CGTX releases positive news about a clinical trial targeting Lewy Bodies. Up 150% premarket... Feels like a trap... Fuck it
calling all regards, CGTX has some mom w/ news and its cheap
It’s super cheap rn despite arguably supportive Ph2 data in AD and especially ahead of the Lewey body dementia Ph2 data expected any day now, so I like the risk/benefit. I don’t have positions in CGTX specifically, I just look at the space https://ir.cogrx.com/press_releases/cognition-therapeutics-announces-all-participants-have-completed-their-final-visits-in-the-phase-2-shimmer-study-of-ct1812-in-dementia-with-lewy-bodies/
I just started building position in CGTX at .40$ for the phase 2 readings results. Are you still invested in it. I know it was while you go this comment but what do you think now?
LODE and a sleeper is CGTX, not alot know about that one
CGTX on a three-day conference in Spain to discuss their results from their latest study. Looking forward to it! [Info](https://www.stocktitan.net/news/CGTX/analyses-from-cognition-s-positive-phase-2-shine-study-of-ct1812-in-9kxc4y7fj57r.html)
That never means anything for efficacy necessarily especially in AD where at best you’re going for slowing of cognitive decline vs. placebo which takes a long time. Look at the Clarity-AD study which was actually a positive trial. SAVA patients are more likely simply tolerating the drug enough to roll over hence the high attrition rate. If anything extremely clean safety would make me think that trades with efficacy and ph3 will fail on the primary endpoint I’d look at ABOS or CGTX targeting the a-beta oligomers with oral drugs, those at least are far more externally validated than SAVA’s drug MOA, and trading far cheaper granted they are still in ph2. SAVA at a >$1B mkt cap is not an attractive risk/reward imo
Yeah I’m in with ~5200 shares but much higher average at $3. Holding some warrants too but same story, had buy limits in at .50 and didn’t buy even when it was at .52!!! What are your predictions with this if phase 3 mirrors phase 2? I’m not in with NVAX. I’m also in heavy with CGTX given they have 5 phase 2 studies In Alzheimer’s and dementia and upward of $200 million from the NIH in funding. It’s a longer term play but preclinical data is matching up with human trials which could be a game changer!
If we aren't worried about cap, check out CGTX https://www.sec.gov/Archives/edgar/data/1455365/000110465922122625/xslF345X03/tm2231503-2_4seq1.xml
CGTX kept up its rise today. Maybe tomorrow too.
This sub has gone to complete shit! Everyone knows that there are major players that are catalyst here. The idea that this sub bashes AMC, GME, and many others makes me believe the mods are bought and paid for. All this other noise (GTII, FNGR, CGTX, and so on) are all a distraction.
CGTX is scam. Shorting it tomorrow at 4am
$CGTX slowly loading on the low volume/down low. Gonna be next big move!! Market Cap 40 million with over 50 million cash. Has 3 Phase 2 studies. 2 presentations next 45 days and data in December for 1 of the phase 2. Other studies coming out in 2023. Most all studies have been all most completely funded by grants. Institutions own 30+% up almost 400% in the last month. $1.88 current price. Float is under 10 million. If phase 2 post solid data this is could run to over $20. Great R/R
$CGTX is getting soaked at the 2-2.2 range and can squeeze easy over $15. It pops hard with no follow through. Blindside squeeze is the play. Just keep it off the wires and soak.